Discordance of HER2 expression in distant metastatic tumors (MTs) versus primary tumors (PTs) in urothelial carcinoma (UC).

Claud Grigg,Chad A. Livasy,Jiaxian He,Aaron Hartman,Peter E. Clark,Derek Raghavan,Earle Frederick Burgess

Discordance of HER2 expression in distant metastatic tumors (MTs) versus primary tumors (PTs) in urothelial carcinoma (UC).

2020

Claud Grigg
Chad A. Livasy
Jiaxian He
Aaron Hartman
Peter E. Clark
Derek Raghavan
Earle Frederick Burgess

550Background: Available HER2 targeted agents have limited benefit for UC, but exceptional tumor responses are occasionally seen. HER2 expression has been tested as a biomarker of response to these...

Keywords:

Oncology
Pathology
Biomarker (medicine)
Carcinoma
Medicine
Internal medicine
her2 expression
urothelial carcinoma
Cancer research

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations